What are my alternatives to knee replacement?
Compare nonsurgical knee arthritis care, injection choices, and selected surgical alternatives—with evidence, limits, and questions for your clinician.
Read the guide ↗Medically reviewed by Charles A. DeCook, MD ·
← All optionsLearn about the evidence
Prolotherapy, ozone & joint Botox
You may hear about them. We do not offer them.
Who might it suit?
For: Checking a proposed injection before spending money.
Not for: An established OA treatment path here.
Limits and important cautions
ACR conditionally recommends against prolotherapy and joint botulinum toxin. That recommendation does not evaluate every ozone protocol; ingredient-specific assessment is essential.
What happens, how long, and what could it cost?
- What happens
- Ask the clinician to explain the exact product or procedure and confirm the diagnosis before treatment.
- When might I notice a change?
- A reliable personal timeline cannot be predicted from the evidence reviewed here. Agree on a review date before starting.
- How long might benefit last?
- Benefit and durability depend on the exact intervention and population. The evidence section below explains what is known.
- Repeat treatment
- Agree on a review date and criteria for continuing, changing, or stopping.
- Activity and recovery
- Ask who provides follow-up, what symptoms need urgent attention, and what restrictions apply to you.
- Ask for a complete estimate
- Consultation, exact product or procedure, any tests, follow-up, and repeat treatment.
Use this as a consultation guide. A timeline is not a guarantee; the evidence and FDA sections below remain part of the decision.
THE EVIDENCE IN CONTEXT
Not established as routine OA care
Read the 2 selected references
- ACR/Arthritis Foundation: OA management ↗
2019 guideline, published in 2020. Recommendations vary by joint; it predates many newer trials.
- Lino et al.: ozone therapy for knee OA ↗
Some reviews found pain benefit, but all eight reviews received critically low confidence ratings. Inconsistent function results and methodological limitations prevent reliable comparative conclusions.
FDA status
No OA approval established hereThis catalog does not establish an FDA-approved osteoarthritis indication for prolotherapy, ozone, or joint Botox. An approved ingredient or drug for another use does not establish approval of an OA injection. Confirm the exact substance, formulation, and route.
Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.What do professional guidelines say?
ACR: Recommends against prolotherapy and intra-articular botulinum toxin for knee or hip OA; no endorsement of ozone.
Will Medicare cover it?
No routine OA coverage.